Baidu
map

Lancet Psychiatry :霸凌是青少年发生精神障碍的强烈危险因素

2015-06-03 Lianghuaibin 译 MedSci原创

被霸凌(欺凌)的经历会对受害人产生或短期或长期的不良影响。这种发病的过程符合生物心理社会医学模式。研究者使用不列颠成人精神疾病发病情况问卷调查2000年和2007年两年的问卷数据来验证假说:霸凌经历和精神障碍发生有关。霸凌可以预测随后出现的被害妄想、幻觉症状。研究者分析了两项针对16岁青少年或者稍大年龄的人群的代表性的问卷调查:2000大不列颠研究,2007英格兰研究,研究者通过向受调查对象展示一



霸凌(欺凌)的经历会对受害人产生或短期或长期的不良影响。这种发病的过程符合生物心理社会医学模式。研究者使用不列颠成人精神疾病发病情况问卷调查2000年和2007年两年的问卷数据来验证假说:霸凌经历和精神障碍发生有关。霸凌可以预测随后出现的被害妄想、幻觉症状。

研究者分析了两项针对16岁青少年或者稍大年龄的人群的代表性的问卷调查:2000大不列颠研究,2007英格兰研究,研究者通过向受调查对象展示一张罗列了压力性事件的卡片来识别其既往有无霸凌经历,评估和被害妄想、听视觉幻觉、可能精神障碍的关系。所有分析过程都对社会人口层面上的混杂因素、智商(IQ)、外伤进行了控制。

研究发现:2000年的调查研究者获得了8580分问卷,2007年的研究获得了7403分问卷,数据分析显示受霸凌经历和被害妄想和幻觉相关。调整混杂因素后,相关仍然存在。受霸凌也和诊断为可能精神障碍相关,基于2000年的问卷调查显示:如果在基线时期即有着霸凌经历,那么这将预示着在接下来的18个随访月内被害妄想和幻觉将会出现和持续的可能性很大。控制混杂因素后,这种相关仍然存在,仅仅会表现为诊断为可能精神障碍的显著性降低。被霸凌的生活经历和被害妄想和幻觉两组症状的同时出现显著相关。

研究者说:被霸凌伤害的经历会增加这类人群接下来患精神障碍的风险,这类人群更倾向于会被诊断为可能精神障碍。早期发现霸凌,并给于对应的阻止向精神障碍的方向发展的治疗,会对这类人群的精神状态有很好的改善,最终达到防止精神障碍的发生目的。

原始出处:

Gennaro Catone, PhD, Steven Marwaha, PhD, Prof Elizabeth Kuipers, PhD, Belinda Lennox, DM, Prof Daniel Freeman, PhD, Prof Paul Bebbington, PhD, Dr Matthew Broome, PhD Bullying victimisation and risk of psychotic phenomena: analyses of British national survey data The Lancet Psychiatry Published Online: 20 May 2015 Article has an altmetric score of 110 DOI: http://dx.doi.org/10.1016/S2215-0366(15)00055-3

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=181001, encodeId=6669181001b5, content=感谢分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20971999626, createdName=laymankey, createdTime=Sun Mar 19 00:04:36 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828134, encodeId=c01618281341b, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jun 22 08:38:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791921, encodeId=6d0e1e919210b, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Apr 13 03:38:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27898, encodeId=f0bb2e898f8, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27899, encodeId=894f2e8999d, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27900, encodeId=02942e900cb, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25856, encodeId=511525856b4, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ead2109432, createdName=illustrator, createdTime=Wed Jun 03 18:26:00 CST 2015, time=2015-06-03, status=1, ipAttribution=)]
    2017-03-19 laymankey

    感谢分享一下!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=181001, encodeId=6669181001b5, content=感谢分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20971999626, createdName=laymankey, createdTime=Sun Mar 19 00:04:36 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828134, encodeId=c01618281341b, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jun 22 08:38:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791921, encodeId=6d0e1e919210b, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Apr 13 03:38:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27898, encodeId=f0bb2e898f8, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27899, encodeId=894f2e8999d, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27900, encodeId=02942e900cb, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25856, encodeId=511525856b4, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ead2109432, createdName=illustrator, createdTime=Wed Jun 03 18:26:00 CST 2015, time=2015-06-03, status=1, ipAttribution=)]
    2015-06-22 howi
  3. [GetPortalCommentsPageByObjectIdResponse(id=181001, encodeId=6669181001b5, content=感谢分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20971999626, createdName=laymankey, createdTime=Sun Mar 19 00:04:36 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828134, encodeId=c01618281341b, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jun 22 08:38:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791921, encodeId=6d0e1e919210b, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Apr 13 03:38:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27898, encodeId=f0bb2e898f8, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27899, encodeId=894f2e8999d, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27900, encodeId=02942e900cb, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25856, encodeId=511525856b4, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ead2109432, createdName=illustrator, createdTime=Wed Jun 03 18:26:00 CST 2015, time=2015-06-03, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=181001, encodeId=6669181001b5, content=感谢分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20971999626, createdName=laymankey, createdTime=Sun Mar 19 00:04:36 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828134, encodeId=c01618281341b, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jun 22 08:38:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791921, encodeId=6d0e1e919210b, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Apr 13 03:38:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27898, encodeId=f0bb2e898f8, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27899, encodeId=894f2e8999d, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27900, encodeId=02942e900cb, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25856, encodeId=511525856b4, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ead2109432, createdName=illustrator, createdTime=Wed Jun 03 18:26:00 CST 2015, time=2015-06-03, status=1, ipAttribution=)]
    2015-06-17 summer474cn

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=181001, encodeId=6669181001b5, content=感谢分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20971999626, createdName=laymankey, createdTime=Sun Mar 19 00:04:36 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828134, encodeId=c01618281341b, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jun 22 08:38:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791921, encodeId=6d0e1e919210b, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Apr 13 03:38:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27898, encodeId=f0bb2e898f8, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27899, encodeId=894f2e8999d, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27900, encodeId=02942e900cb, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25856, encodeId=511525856b4, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ead2109432, createdName=illustrator, createdTime=Wed Jun 03 18:26:00 CST 2015, time=2015-06-03, status=1, ipAttribution=)]
    2015-06-17 summer474cn

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=181001, encodeId=6669181001b5, content=感谢分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20971999626, createdName=laymankey, createdTime=Sun Mar 19 00:04:36 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828134, encodeId=c01618281341b, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jun 22 08:38:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791921, encodeId=6d0e1e919210b, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Apr 13 03:38:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27898, encodeId=f0bb2e898f8, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27899, encodeId=894f2e8999d, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27900, encodeId=02942e900cb, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25856, encodeId=511525856b4, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ead2109432, createdName=illustrator, createdTime=Wed Jun 03 18:26:00 CST 2015, time=2015-06-03, status=1, ipAttribution=)]
    2015-06-17 summer474cn

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=181001, encodeId=6669181001b5, content=感谢分享一下!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20971999626, createdName=laymankey, createdTime=Sun Mar 19 00:04:36 CST 2017, time=2017-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1828134, encodeId=c01618281341b, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Mon Jun 22 08:38:00 CST 2015, time=2015-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791921, encodeId=6d0e1e919210b, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Wed Apr 13 03:38:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27898, encodeId=f0bb2e898f8, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27899, encodeId=894f2e8999d, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27900, encodeId=02942e900cb, content=!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://api.medsci.cn/resource/upload/20150526/IMG5564536F3C41D5237.jpg, createdBy=4c0c1612254, createdName=summer474cn, createdTime=Wed Jun 17 08:45:00 CST 2015, time=2015-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25856, encodeId=511525856b4, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ead2109432, createdName=illustrator, createdTime=Wed Jun 03 18:26:00 CST 2015, time=2015-06-03, status=1, ipAttribution=)]
    2015-06-03 illustrator

    有意思

    0

相关资讯

Nat Commun:为何有些人抗压能力更强?

有些人比其他人更能应对压力情况,并不完全是因为遗传学因素,即使同卵双胞胎在应对压力方面也存在差异。 最近,研究人员在基因完全相同的小鼠大脑中,发现了一种特殊的电模式,可预测动物如何很好地应对压力情况。相关研究结果发表在2014年7月29日的 Nature Communications 杂志,可能最终会帮助研究人员在易于出现精神障碍的人当中,预防潜在的慢性压力的后果,例如创伤应激

Neuron:帮助诊断治疗精神障碍的microRNA分子

据世界卫生组织统计,情绪障碍如抑郁症影响到世界人口的约10%,世界各地的许多科学家们在了解这些疾病中投入了大量的心血,然而,精神障碍背后的分子和细胞机制仍然只有获得了部分理解。现有的抗抑郁药都不够好:有60-70%患者得不到任何帮助,对于其他的30-40%患者,疾病的帮助往往是不彻底的,他们必须在获得任何效果之前很长时间服用药物。另外,有些药物出现了药物相关的许多副作用。因此,显然需要新的和更好

Lancet Neurol:卒中后精神障碍诊治临床综述

导读:全球每年大约有1600万新发卒中患者,其中约有570万人死亡,其他500万人遗留残疾。卒中后精神障碍十分常见,对患者及其家属造成巨大的痛苦和负担,但尚未得到医疗专业人士的重视,患者的治疗需求也未得到满足。在该篇综述中,研究者关注卒中后最常见的非认知功能性的神经精神症状——如抑郁,焦虑,情绪不稳以及淡漠。研究者也讨论了卒中后疲劳,人格改变,重度精神病,躁狂等。对于每一种神经精神障碍,均讨论

JAMA:社区特点对精神健康的影响或存性别差异

据3月5日刊《美国医学会杂志》上的一则研究披露,对那些搬离高度贫困社区的家庭而言,这些家庭中的男孩经历了抑郁症及行为障碍比率的增加而女孩在这些方面则有下降。 观察性研究总是发现,在高度贫困社区中的青少年有着情绪问题的高发病这些发现提出了社区特点会影响情绪功能,而社区层面的干预可能会减少情绪问题的可能性。根据文章的背景资料,来自可获得的观察性研究的数据是不清楚的。“了解社区对精神健康的影响对构

Lancet Psychiatry:精神障碍患者中糖尿病的亟需两科室医师更深的沟通和合作

精神障碍患者当中常常会合并或者表现出严重程度不等的糖尿病症状。包括糖尿病患病率增加,预后相对较差,糖尿病并发症和死亡率的增高。目前来说,鉴于精神科医师对糖尿病认识的有限和系统治疗方式的不足,对血糖异常的低质量的医疗处理方式是导致病人预后较差的显著祸首。一份深思熟虑的糖尿病共病药物治疗方案和精神障碍药物治疗的制定对于应对精神病人出现糖尿病征兆和症状是至关重要。不管这份标准治疗方案是为精神科医师、一级

Lancet Psychiatry :精神障碍患者中糖尿病的流行病学研究

糖尿病在精神障碍患者当中有着显著增高的患病率,精神障碍包括精神分裂症和分裂样情感障碍。因为在精神科中,有许多糖尿病并未被临床医师发现,究竟精神障碍患者当中糖尿病的发病率有多高,确切的流行病学数据很难估计。基于目前的几个研究数据,精神障碍患者的糖尿病发病率显著高于普通人群,患病率从1.26%到50%不等,中位患病率13%。糖尿病和精神障碍的关系是复杂的且是多因素作用的结果。多种传统上的致病危险因素对

Baidu
map
Baidu
map
Baidu
map